METHODS: Over a 20-year period, 87.0% (40/46) of patients received TAE as first-line treatment. The clinical presentation, angiographic features, treatment strategy, and clinical and angiographic outcomes are described in this article.
RESULTS: Forty patients underwent TAE as first-line treatment. There were 36 men and 4 women, with a mean age of 55.6 (55.6±7.4) years. A total of 64 embolization attempts were performed. The middle meningeal artery (66.7%, 12/18) and the ophthalmic artery (54.2%, 13/24) were the most frequently used arterial access routes for complete embolization. The second option was the sphenopalatine artery (46.7%, 7/15). Complications, that is, retinal ischemia, occurred in one patient (2.5%). The total immediate complete occlusion rate for TAE was 82.5% (33/40). Two patients needed surgery for incomplete embolization. When followed up (90%, 36/40), one patient (2.8%, 1/36) reported worsening symptoms due to retinal ischemia following TAE. Although fewer than 50% of the patients received digital subtraction angiography follow-up, there were no recurrences.
CONCLUSIONS: We show that TAE is safe and effective in the treatment of ACF DAVFs in this study of 40 patients, making it a viable alternative to surgical ligation and transvenous embolization. More research is needed to compare these various treatment modalities.
方法:在20年的时间里,87.0%(40/46)的患者接受TAE作为一线治疗。临床表现,血管造影特征,治疗策略,本文描述了临床和血管造影结果。
结果:40例患者接受TAE作为一线治疗。有36名男性和4名女性,平均年龄55.6(55.6±7.4)岁。总共进行了64次栓塞尝试。脑膜中动脉(66.7%,12/18)和眼动脉(54.2%,13/24)是用于完全栓塞的最常用的动脉入路。第二种选择是蝶腭动脉(46.7%,7/15).并发症,也就是说,视网膜缺血,1例患者(2.5%)。TAE的总即刻完全闭塞率为82.5%(33/40)。两名患者因不完全栓塞需要手术。随访时(90%,36/40),一名患者(2.8%,1/36)报告TAE后由于视网膜缺血导致症状恶化。虽然不到50%的患者接受了数字减影血管造影随访,没有复发。
结论:我们表明,在这项40例患者的研究中,TAE治疗ACFDAVFs是安全有效的,使其成为手术结扎和经静脉栓塞的可行替代方案。需要更多的研究来比较这些不同的治疗方式。